Hospital management of adults with severe acute respiratory syndrome (SARS) if SARS re-emerges - Updated 10 February 2004

Journal of Infection

Volumn 49, Issue 1, 2004, Pages 1-7

  Lim, W S ^a   Anderson, S R ^a   Read, R C ^a  

^a NONE

Author keywords

Case definitions; SARS; UK guidelines

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA INTERFERON; CEFUROXIME; CLARITHROMYCIN; ERYTHROMYCIN; INTERFERON; METHYLPREDNISOLONE; OXYGEN; PREDNISOLONE; RIBAVIRIN; STEROID;

ANTIVIRAL ACTIVITY; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; CLINICAL PRACTICE; CLINICAL TRIAL; COUGHING; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISEASE TRANSMISSION; DOSE RESPONSE; DYSPNEA; EMERGENCY TREATMENT; ENDOTRACHEAL INTUBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; FLUID THERAPY; FOLLOW UP; HAND WASHING; HEALTH PRACTITIONER; HEMOLYSIS; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; INFECTION CONTROL; INTENSIVE CARE; LABORATORY TEST; MONITORING; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OXYGEN THERAPY; PATIENT TRANSPORT; PNEUMONIA; POLYMERASE CHAIN REACTION; PROBABILITY; PROTECTIVE CLOTHING; PULSE OXIMETRY; REVIEW; SAFETY; SEVERE ACUTE RESPIRATORY SYNDROME; SURGICAL MASK; THORAX RADIOGRAPHY;

EID: 3242669905     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2004.04.001     Document Type: Article

References (17)

1. Booth C.M. Matukas L.M. Tomlinson G.A. et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area JAMA 289 2003 2801-2809
2. Peiris J.S. Lai S.T. Poon L.L. et al. Coronavirus as a possible cause of severe acute respiratory syndrome Lancet 361 9366 2003 1319-1325
3. Lew T.W. Kwek T.K. Tai D. et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome JAMA 290 3 2003 374-380
4. Fowler R.A. Lapinsky S.E. Hallett D. et al. Critically ill patients with severe acute respiratory syndrome JAMA 290 3 2003 367-373
5. Fouchier R.A. Kuiken T. Schutten M. et al. Aetiology: Koch's postulates fulfilled for SARS virus Nature 423 6937 2003 240
6. Seto W.H. Tsang D. Yung R.W. et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS) Lancet 361 9368 2003 1449-1456
7. Peiris J.S. Chu C.M. Cheng V.C. et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Lancet 361 9371 2003 1767-1772
8. Poutanen S.M. Low D.E. Henry B. et al. Identification of severe acute respiratory syndrome in Canada N Engl J Med 348 20 2003 1995-2005
9. Lee N. Hui D. Wu A. et al. A major outbreak of severe acute respiratory syndrome in Hong Kong N Engl J Med 348 20 2003 1986-1994
10. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001;56 (Suppl. 4):IV1-64.
11. Li T.S. Buckley T.A. Yap F.H. Sung J.J. Joynt G.M. Severe acute respiratory syndrome (SARS): infection control Lancet 361 9366 2003 1386
12. Tomlinson B. Cockram C. SARS: experience at Prince of Wales Hospital, Hong Kong Lancet 361 9368 2003 1486-1487
13. Kamming D. Gardam M. Chung F. Anaesthesia and SARS Br. J. Anaesth. 90 6 2003 715-718
14. So L.K. Lau A.C. Yam L.Y. et al. Development of a standard treatment protocol for severe acute respiratory syndrome Lancet 361 9369 2003 1615-1617
15. Zhao Z. Zhang F. Xu M. et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China J Med Microbiol 52 Part 8 2003 715-720
16. Ho J.C. Ooi G.C. Mok T.Y. et al. High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome Am J Respir Crit Care Med 2003
17. Cinatl J. Chandra P. Rabenau H. Doerr H.W. Treatment of SARS with human interferons Lancet 362 9390 2003 1158-1159